Patents by Inventor Ashish Kumar Rehni

Ashish Kumar Rehni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160176890
    Abstract: The present invention is directed to oral pharmaceutical compositions of buprenorphine and it pharmaceutically acceptable salts and the use thereof.
    Type: Application
    Filed: March 1, 2016
    Publication date: June 23, 2016
    Applicant: Relmada Therapeutics, Inc.
    Inventors: Najib BABUL, Ashish Kumar Rehni
  • Publication number: 20120178771
    Abstract: The present invention is directed to oral, therapeutically effective pharmaceutical compositions of buprenorphine and it pharmaceutically acceptable salts and the use thereof, including delayed onset and controlled release dosage forms. The present invention is also directed delayed onset, rapid release dosage forms and delayed onset, extended release dosage forms of oral buprenorphine which provide robust efficacy and reduced potential for abuse and misuse.
    Type: Application
    Filed: September 9, 2011
    Publication date: July 12, 2012
    Inventors: Najib BABUL, Ashish Kumar Rehni
  • Publication number: 20110097395
    Abstract: The present invention is directed to oral pharmaceutical compositions of buprenorphine and it pharmaceutically acceptable salts and the use thereof.
    Type: Application
    Filed: March 9, 2009
    Publication date: April 28, 2011
    Inventors: Najib Babul, Ashish Kumar Rehni